Abstract:Deoxynivalenol (DON) is a widespread mycotoxin and causes anorexia and emesis in humans and animals; Lactobacillus rhamnosus GG (LGG), a well-characterized probiotic, can improve intestinal barrier function and modulate immune response. Currently, it is unclear whether LGG has a beneficial effect on DON-induced anorexia. In the present study, mice were treated with DON, LGG, or both by gavage for 28 days to evaluate the effects of LGG on DON-induced anorexia. Antibiotic treatment and fecal microbiota transplant (FMT) experiment were also conducted to investigate the link between DON, LGG, and gut microbiota. LGG significantly increased the villus height and reduced the crypt depth in jejunum and ileum, enhanced the tight junction proteins expression in the intestine, and regulated the TLR4/NF-κB signaling pathway, consequently attenuating the intestinal inflammation caused by DON. In addition, LGG increased the relative abundance of Lactobacillus and butyric acid production of cecal contents; remodeled phenylalanine metabolism and tryptophan metabolism; reduced plasma peptide tyrosine tyrosine (PYY), 5-hydroxytryptamine (5-HT), and glucagon-like peptide-1 (GLP-1) concentrations; and promoted hypothalamic NPY and AgPR gene expression, which will further promote food intake and reduce weight loss, ultimately alleviating DON-induced anorexia in mice. Interestingly, antibiotic treatment diminished the intestinal toxicity of DON. The FMT experiment showed that DON-originated microbiota promotes intestinal inflammation and anorexia, while LGG + DON-originated microbiota has no adverse effects on mice. Both antibiotic treatment and FMT experiment have proved that gut microbiota was the primary vector for DON to exert its toxic effects and an essential mediator of LGG protection. In summary, our findings demonstrate that gut microbiota plays essential roles in DON-induced anorexia, and LGG can reduce the adverse effects caused by DON through its structure and regulate the gut microbiota, which may lay the important scientific foundation for future applications of LGG in food and feed products.

Protective Effect of Devosia Sp. ANSB714 on Growth Performance, Serum Chemistry, Immunity Function and Residues in Kidneys of Mice Exposed to Deoxynivalenol.

Effects of Devosia sp .ANSB714 on performance,immunity and antioxidation function of mice exposed to deoxynivalenol

Protective Effects of Devosia Sp. ANSB714 on Growth Performance, Immunity Function, Antioxidant Capacity and Tissue Residues in Growing-Finishing Pigs Fed with Deoxynivalenol Contaminated Diets.

Deoxynivalenol Exposure Induces Liver Damage in Mice: Inflammation and Immune Responses, Oxidative Stress, and Protective Effects of Lactobacillus Rhamnosus GG.

Protective Effects of Bacillus Subtilis ASAG 216 on Growth Performance, Antioxidant Capacity, Gut Microbiota and Tissues Residues of Weaned Piglets Fed Deoxynivalenol Contaminated Diets

Effects of Increasing Oral Deoxynivalenol Gavage on Growth Performance, Blood Biochemistry, Metabolism, Histology, and Microbiome in Rats

Deoxynivalenol Photocatalytic Detoxification Products Alleviate Intestinal Barrier Damage and Gut Flora Disorder in BLAB/c Mice

Conversion of DON to 3-epi-DON in vitro and toxicity reduction of DON in vivo by Lactobacillus rhamnosus.

Lactobacillus rhamnosus GG ameliorates deoxynivalenol-induced kidney oxidative damage and mitochondrial injury in weaned piglets.

Deoxynivalenol-mediated kidney injury via endoplasmic reticulum stress in mice

Toxicology of 3-Epi-deoxynivalenol, a Deoxynivalenol-Transformation Product by Devosia Mutans 17-2-E-8.

Effects of Deoxynivalenol on the Porcine Growth Performance and Intestinal Microbiota and Potential Remediation by a Modified HSCAS Binder

Effect of deoxynivalenol on the porcine acquired immune response and potential remediation by a novel modified HSCAS adsorbent

Efficacy of High-Dose Synbiotic Additives for Deoxynivalenol Detoxification: Effects on Blood Biochemistry, Histology, and Intestinal Microbiome in Weaned Piglets

Maternal Exposure to DON During Lactation Induces Testicular Toxicity in Pubertal and Adult Offspring Mice

Isolation and Characterization of a Deoxynivalenol-Degrading Bacterium Bacillus Licheniformis YB9 with the Capability of Modulating Intestinal Microbial Flora of Mice.

Effects of dietary deoxynivalenol on growth performance and organ accumulation of growing pigs

Ameliorative Effects of Luteolin and Activated Charcoal on Growth Performance, Immunity Function, and Antioxidant Capacity in Broiler Chickens Exposed to Deoxynivalenol

Gly-Pro-Ala peptide and FGSHF3 exert protective effects in DON-induced toxicity and intestinal damage via decreasing oxidative stress

Deoxynivalenol induced spermatogenesis disorder by blood-testis barrier disruption associated with testosterone deficiency and inflammation in mice.

Gut Microbiota Mediates Lactobacillus Rhamnosus GG Alleviation of Deoxynivalenol-Induced Anorexia.